Literature DB >> 10802664

Mutations in KERA, encoding keratocan, cause cornea plana.

N S Pellegata1, J L Dieguez-Lucena, T Joensuu, S Lau, K T Montgomery, R Krahe, T Kivelä, R Kucherlapati, H Forsius, A de la Chapelle.   

Abstract

Specialized collagens and small leucine-rich proteoglycans (SLRPs) interact to produce the transparent corneal structure. In cornea plana, the forward convex curvature is flattened, leading to a decrease in refraction. A more severe, recessively inherited form (CNA2; MIM 217300) and a milder, dominantly inherited form (CNA1; MIM 121400) exist. CNA2 is a rare disorder with a worldwide distribution, but a high prevalence in the Finnish population. The gene mutated in CNA2 was assigned by linkage analysis to 12q (refs 4, 5), where there is a cluster of several SLRP genes. We cloned two additional SLRP genes highly expressed in cornea: KERA (encoding keratocan) in 12q and OGN (encoding osteoglycin) in 9q. Here we report mutations in KERA in 47 CNA2 patients: 46 Finnish patients are homozygous for a founder missense mutation, leading to the substitution of a highly conserved amino acid; and one American patient is homozygous for a mutation leading to a premature stop codon that truncates the KERA protein. Our data establish that mutations in KERA cause CNA2. CNA1 patients had no mutations in these proteoglycan genes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10802664     DOI: 10.1038/75664

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  43 in total

1.  Corneal collagen fibril structure in three dimensions: Structural insights into fibril assembly, mechanical properties, and tissue organization.

Authors:  D F Holmes; C J Gilpin; C Baldock; U Ziese; A J Koster; K E Kadler
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-05       Impact factor: 11.205

Review 2.  The Finnish Disease Heritage III: the individual diseases.

Authors:  Reijo Norio
Journal:  Hum Genet       Date:  2003-03-08       Impact factor: 4.132

3.  Cornea plana associated with open-angle glaucoma: a case report.

Authors:  Bilge Ozturk Sahin; Goktug Seymenoglu; Esin F Baser
Journal:  Int Ophthalmol       Date:  2011-12-11       Impact factor: 2.031

4.  [Gene expression in keratoconus. Initial results using DNA microarrays].

Authors:  A Bochert; J Berlau; D Koczan; B Seitz; H J Thiessen; R Guthoff
Journal:  Ophthalmologe       Date:  2003-06-07       Impact factor: 1.059

5.  Linkage of posterior amorphous corneal dystrophy to chromosome 12q21.33 and exclusion of coding region mutations in KERA, LUM, DCN, and EPYC.

Authors:  Anthony J Aldave; George O D Rosenwasser; Vivek S Yellore; Jeanette C Papp; Eric M Sobel; Michele N Pham; Michael C Chen; Sugandha Dandekar; Ram Sripracha; Sylvia A Rayner; Joseph W Sassani; Michael B Gorin
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-03-31       Impact factor: 4.799

6.  Pellucid marginal degeneration coexistent with cornea plana in one member of a family exhibiting a novel KERA mutation.

Authors:  A O Khan; M Aldahmesh; A Al-Saif; B Meyer
Journal:  Br J Ophthalmol       Date:  2005-11       Impact factor: 4.638

Review 7.  Extracellular matrix molecules: potential targets in pharmacotherapy.

Authors:  Hannu Järveläinen; Annele Sainio; Markku Koulu; Thomas N Wight; Risto Penttinen
Journal:  Pharmacol Rev       Date:  2009-06       Impact factor: 25.468

Review 8.  Biological functions of the small leucine-rich proteoglycans: from genetics to signal transduction.

Authors:  Liliana Schaefer; Renato V Iozzo
Journal:  J Biol Chem       Date:  2008-05-06       Impact factor: 5.157

Review 9.  Roles of lumican and keratocan on corneal transparency.

Authors:  Winston W-Y Kao; Chia-Yang Liu
Journal:  Glycoconj J       Date:  2002 May-Jun       Impact factor: 2.916

Review 10.  Small leucine-rich repeat proteoglycans in corneal inflammation and wound healing.

Authors:  Jihane Frikeche; George Maiti; Shukti Chakravarti
Journal:  Exp Eye Res       Date:  2016-08-26       Impact factor: 3.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.